3,004 Shares in Innospec Inc. (NASDAQ:IOSP) Purchased by XTX Topco Ltd

XTX Topco Ltd acquired a new stake in Innospec Inc. (NASDAQ:IOSP) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,004 shares of the specialty chemicals company’s stock, valued at approximately $371,000.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Innospec by 5.5% during the 1st quarter. Vanguard Group Inc. now owns 3,115,167 shares of the specialty chemicals company’s stock worth $401,670,000 after purchasing an additional 161,249 shares during the period. Wasatch Advisors LP grew its position in Innospec by 1.1% during the first quarter. Wasatch Advisors LP now owns 1,972,110 shares of the specialty chemicals company’s stock worth $254,284,000 after buying an additional 22,094 shares during the period. Bank of New York Mellon Corp increased its holdings in Innospec by 2.4% in the second quarter. Bank of New York Mellon Corp now owns 258,294 shares of the specialty chemicals company’s stock valued at $31,923,000 after buying an additional 6,148 shares in the last quarter. Norges Bank acquired a new stake in shares of Innospec during the 4th quarter valued at approximately $25,925,000. Finally, Eagle Asset Management Inc. boosted its stake in shares of Innospec by 4.6% during the 4th quarter. Eagle Asset Management Inc. now owns 198,344 shares of the specialty chemicals company’s stock worth $24,444,000 after acquiring an additional 8,644 shares in the last quarter. Hedge funds and other institutional investors own 96.64% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com downgraded Innospec from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th.

Insider Activity at Innospec

In other Innospec news, CFO Ian Cleminson sold 3,398 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $114.74, for a total transaction of $389,886.52. Following the completion of the transaction, the chief financial officer now owns 12,996 shares of the company’s stock, valued at $1,491,161.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.52% of the stock is owned by corporate insiders.

Innospec Stock Up 2.3 %

NASDAQ:IOSP opened at $113.81 on Friday. The company has a market capitalization of $2.84 billion, a PE ratio of 19.32 and a beta of 1.08. Innospec Inc. has a 52-week low of $95.69 and a 52-week high of $133.71. The stock has a fifty day simple moving average of $114.49 and a 200-day simple moving average of $121.45.

Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.02. The company had revenue of $435.00 million during the quarter, compared to analysts’ expectations of $468.73 million. Innospec had a net margin of 7.90% and a return on equity of 14.15%. The firm’s quarterly revenue was down 9.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.28 earnings per share. As a group, equities analysts anticipate that Innospec Inc. will post 5.95 earnings per share for the current year.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.